Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 4 | ||
Ligand | BDBM50246772 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1676839 (CHEMBL4026982) | ||
IC50 | 9.0±n/a nM | ||
Citation | Scott, JS; Degorce, SL; Anjum, R; Culshaw, J; Davies, RDM; Davies, NL; Dillman, KS; Dowling, JE; Drew, L; Ferguson, AD; Groombridge, SD; Halsall, CT; Hudson, JA; Lamont, S; Lindsay, NA; Marden, SK; Mayo, MF; Pease, JE; Perkins, DR; Pink, JH; Robb, GR; Rosen, A; Shen, M; McWhirter, C; Wu, D Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88 J Med Chem60:10071-10091 (2017) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 4 | |||
Name: | Interleukin-1 receptor-associated kinase 4 | ||
Synonyms: | IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64 | ||
Type: | Protein | ||
Mol. Mass.: | 51519.08 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9NWZ3 | ||
Residue: | 460 | ||
Sequence: |
| ||
BDBM50246772 | |||
n/a | |||
Name | BDBM50246772 | ||
Synonyms: | CHEMBL4086115 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H38N6O2 | ||
Mol. Mass. | 454.6082 | ||
SMILES | CN(C)C(=O)C1CCN(CC1)[C@H]1CC[C@@H](CC1)Nc1ncnc2[nH]cc(C3CCOCC3)c12 |r,wU:14.18,wD:11.11,(20.57,-15.78,;20.58,-14.24,;21.92,-13.48,;19.26,-13.46,;19.27,-11.92,;17.92,-14.22,;17.91,-15.76,;16.58,-16.52,;15.25,-15.74,;15.25,-14.21,;16.59,-13.44,;13.92,-16.51,;12.58,-15.74,;11.24,-16.5,;11.25,-18.05,;12.58,-18.81,;13.91,-18.05,;9.92,-18.82,;9.92,-20.36,;11.26,-21.12,;11.26,-22.67,;9.92,-23.44,;8.59,-22.67,;7.12,-23.15,;6.21,-21.91,;7.11,-20.65,;6.62,-19.19,;7.64,-18.04,;7.16,-16.58,;5.65,-16.27,;4.63,-17.42,;5.11,-18.88,;8.58,-21.12,)| | ||
Structure |